https://pharmadog.xyz/news/591083 pharmadog en 2026-10-25T10:00:51.000Z Pfizer shifts focus after lung cancer trial setback, cites early signals in earlier-line patients; BioNTech and BMS report initial activity https://pharmadog.xyz/news/590683 pharmadog en 2026-10-25T08:31:01.000Z Merck and Moderna’s mRNA melanoma vaccine cuts recurrence risk by 42% in Phase 3 trial https://pharmadog.xyz/news/588254 pharmadog en 2026-10-24T18:23:00.000Z Tonight We Ride recalls Ultimate Forza male supplement after finding undeclared sildenafil, tadalafil and dapoxetine https://pharmadog.xyz/news/587731 pharmadog en 2026-10-24T17:00:59.000Z Amgen and AstraZeneca present new combo data for extensive-stage small cell lung cancer at ESMO https://pharmadog.xyz/news/587411 pharmadog en 2026-10-24T16:00:12.000Z AstraZeneca, Lilly and Bayer unveil new strategies at ESMO 2026 in Madrid https://pharmadog.xyz/news/587075 pharmadog en 2026-10-24T14:30:56.000Z Amgen's Imdelltra plus AstraZeneca's Imfinzi cuts death risk by 58% in small cell lung cancer Phase 3 trial https://pharmadog.xyz/news/586340 pharmadog en 2026-10-24T11:00:00.000Z Opinion reflects on Theranos failures and the impracticality of its testing model https://pharmadog.xyz/news/586339 pharmadog en 2026-10-24T11:00:00.000Z Christina Applegate’s misdiagnosis highlights ongoing challenges in multiple sclerosis diagnosis https://pharmadog.xyz/news/586295 pharmadog en 2026-10-24T10:00:25.000Z Merck and Moderna present Phase 3 cancer vaccine data at ESMO26 amid Treasury proposal on China investment https://pharmadog.xyz/news/586438 pharmadog en 2026-10-24T06:25:00.000Z Merck and Moderna disclose phase 3 cancer vaccine data early after leak, showing improved recurrence-free survival with Keytruda https://pharmadog.xyz/news/584123 pharmadog en 2026-10-23T23:15:09.000Z Swiss biotech Windward Bio files for Nasdaq IPO to raise funds for China-derived assets and R&D https://pharmadog.xyz/news/583388 pharmadog en 2026-10-23T19:16:37.000Z ADA admits unclear policies after ejecting members, sparks boycott and journal shutdown https://pharmadog.xyz/news/583111 pharmadog en 2026-10-23T18:55:12.000Z Patient dies in Bristol Myers Squibb autoimmune CAR-T trial, raising safety concerns https://pharmadog.xyz/news/583112 pharmadog en 2026-10-23T18:48:10.000Z Few European-approved cancer drugs deliver high clinical benefit, analysis shows https://pharmadog.xyz/news/583067 pharmadog en 2026-10-23T18:36:40.000Z Bristol Myers Squibb identifies cause of safety signal in lupus CAR‑T trial https://pharmadog.xyz/news/582923 pharmadog en 2026-10-23T17:00:09.000Z BMS reports fatal septic pneumonia in MS patient during CAR T trial of zolacabtagene autoleucel https://pharmadog.xyz/news/582943 pharmadog en 2026-10-23T16:47:31.000Z Novartis MS drug remibrutinib cuts relapse rates by about a third in Phase 3 trials https://pharmadog.xyz/news/582944 pharmadog en 2026-10-23T16:39:04.000Z Writer empathizes with Christina Applegate’s MS misdiagnosis, recalling her own 13-year diagnostic journey https://pharmadog.xyz/news/582627 pharmadog en 2026-10-23T15:59:07.000Z Callio Therapeutics appoints Chris Hassig as chief scientific officer, coming from Boundless Bio https://pharmadog.xyz/news/582628 pharmadog en 2026-10-23T15:48:21.000Z STAT honors late infectious disease reporter Helen Branswell on The Readout LOUD podcast https://pharmadog.xyz/news/582795 pharmadog en 2026-10-23T15:33:00.000Z RNAi developers see surge in IPOs and funding as industry interest revives https://pharmadog.xyz/news/582607 pharmadog en 2026-10-23T15:27:30.000Z Alnylam to launch pivotal Huntington’s trial after early study shows strong huntingtin knockdown https://pharmadog.xyz/news/582629 pharmadog en 2026-10-23T15:24:28.000Z Tango’s pancreatic cancer combo shows striking promise at ESMO, building on Revolution Medicines’ earlier success https://pharmadog.xyz/news/582608 pharmadog en 2026-10-23T15:21:21.000Z Tango Therapeutics reports 82% response rate for vopimetostat plus Rasonque in pancreatic cancer, down from 92% earlier https://pharmadog.xyz/news/582583 pharmadog en 2026-10-23T15:13:11.000Z Lycia Therapeutics raises $317.5 million in IPO as Merck halts sac-TMT trial https://pharmadog.xyz/news/582584 pharmadog en 2026-10-23T15:03:52.000Z Roche signs up to $813M deal with Zymeworks for preclinical trispecific T cell engager https://pharmadog.xyz/news/134233 pharmadog en 2026-10-23T14:55:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/582331 pharmadog en 2026-10-23T14:52:20.000Z Roche warns Germany faces last chance to regain pharma investment confidence https://pharmadog.xyz/news/582351 pharmadog en 2026-10-23T14:47:21.000Z States Challenge New Medicaid Work Requirements in Boston Court https://pharmadog.xyz/news/582307 pharmadog en 2026-10-23T14:33:54.000Z Bristol Myers reports patient death in autoimmune CAR-T trial and explains summer pause https://pharmadog.xyz/news/582163 pharmadog en 2026-10-23T13:54:57.000Z Marengo's bispecific antibody invikafusp alfa shows tumor shrinkage in 8 cancer types in Phase 2 https://pharmadog.xyz/news/582164 pharmadog en 2026-10-23T13:54:40.000Z US proposes new biotech investment limits on China, but licensing deals remain allowed https://pharmadog.xyz/news/582183 pharmadog en 2026-10-23T13:45:14.000Z Personalized mRNA vaccine cuts melanoma recurrence risk by 42% in trial https://pharmadog.xyz/news/582165 pharmadog en 2026-10-23T13:40:08.000Z FDA lifts hold on Aardvark Therapeutics' ARD-101 after safety study shows no cardiac events